Contribution: Industrial Research Assistance Program – Contributions to Firms
ME Therapeutics Inc.
$140,000.00
Design and testing of targeted mRNA therapeutics for the treatment of cancer and inflammatory disease
FY 2025-26 · 2025-04-01
Summary
This project will involve testing the efficacy of a lead mRNA therapeutic and designing of novel mRNA sequence modifications to modulate mRNA expression in a tissue-specific manner.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
837332592
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-03-31
Agreement Number
1029916
Agreement Start Date
2025-04-01
Agreement Title
Design and testing of targeted mRNA therapeutics for the treatment of cancer and inflammatory disease
Agreement Title (French)
Conception et test de traitements ciblés à base d’ARNm pour le traitement du cancer et des maladies inflammatoires
Agreement Type
Contribution
Agreement Value
$140,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will involve testing the efficacy of a lead mRNA therapeutic and designing of novel mRNA sequence modifications to modulate mRNA expression in a tissue-specific manner.
Description (French)
Ce projet consistera à tester l’efficacité d’un traitement à base d’ARNm et à concevoir de nouvelles modifications de séquences d’ARNm afin de moduler l’expression de l’ARNm de manière spécifique à certains tissus.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
837332592
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
ME Therapeutics Inc.
Recipient Postal Code
V6B 0N3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2025-2026-Q1-1029916
